Autor: |
Richard F. Kefford, Daniele Ouellet, Bo Ma, Peter Lebowitz, C. Martin Curtis, Samuel C. Blackman, Steven J. O'Day, Melvin T. Chin, Anna Pavlick, Michael Millward, Jeffrey R. Infante, Omid Hamid, Michael P. Brown, H.-Tobias Arkenau, Kevin B. Kim, Razelle Kurzrock, Georgina V. Long, Gerald S. Falchook |
Rok vydání: |
2023 |
Popis: |
Table S1. Treatment-related adverse events of {greater than or equal to} grade 2 reported in at least 5% of patients by dose (3); Table S2. Summary of plasma dabrafenib pharmacokinetic parameters after single-dose administration of dabrafenib gelatin capsules under fasted conditions (dose escalation: Part 1); Table S3. Summary of plasma dabrafenib pharmacokinetic parameters after repeated dose administration of dabrafenib gelatin capsules under fasting conditions on day 8 or day 15 (dose escalation: Part 1). |
Databáze: |
OpenAIRE |
Externí odkaz: |
|